SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as traders assess market volatility amidst concerns about regional banks and the potential for a trade war with China. Community discussions revolve around potential support levels and whether the market will experience a significant downturn or a bounce. Increasing VIX levels and rising gold prices add to the uncertain outlook, with some participants bracing for a potential market correction.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending downwards as the community debates whether it's a scam or a buying opportunity, with some pointing to the CEO's past sale of shares as a negative signal. Discussions include potential price targets, upcoming earnings, and the overall valuation of the quantum computing sector. Bears anticipate a significant drop, while bulls hope for a rebound, contributing to the stock's volatility.

ZenaTech, Inc. is an enterprise software technology company, which specializes in mission-critical cloud-based applications integrated with smart hardware to deliver solutions across diverse industries. The firm also develops drone manufacturing, sales, and distribution business. The company was founded by Shaun A. Passley on August 31, 2017 and is headquartered in Vancouver, Canada.

ZenaTech Inc.

ZenaTech is trending due to its plans for congressional meetings to promote drone technology and US manufacturing, sparking community interest in its potential impact on securing funding and shaping policy. Community members are discussing the company's strong management, vision, and possible comparison to Droneshield's growth, while highlighting the increasing US government spending on defense drone contracts. The company's focus on AI drones in the growing defense sector is also a key talking point.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

Bitfarms Ltd.

Bitfarms (BITF) is trending due to a recently announced offering of convertible senior notes, initially $300M then increased to $500M, intended to fund corporate needs and hedge against share dilution. While some investors express concerns about potential dilution and management decisions, others view the capital raise as a strategic move to fund expansion into AI and high-performance computing (HPC). The community is actively debating the offering's terms, potential impact, and the company's long-term prospects in the crypto mining and AI sectors.

SharpLink Gaming, Inc. is an online performance-based marketing company, which engages in the provision of online platform facilitating sports betting. It connects sports fans, leagues, and sports websites to relevant and timely sports betting content. The company was founded by Robert Phythian in 2019 and is headquartered in Minneapolis, MN.

SharpLink Gaming Inc.

SharpLink Gaming Ltd

SBET is trending due to a recently priced share offering at a premium, signaling institutional confidence and sparking community discussion about the company's Ethereum strategy. Some investors are excited about the potential for future gains as the company continues to accumulate ETH, while others express concerns about dilution and management's performance relative to peers like BMNR. The stock's movements are closely tied to Ethereum's price, making it a subject of debate as crypto markets experience volatility.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending amid discussions about potential acquisitions and expansion plans, including a possible move into stablecoins and new crypto listings; the community is analyzing technical patterns and speculating on future price movements, while also keeping an eye on Bitcoin's influence and overall market conditions.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors discuss the company's shift towards AI cloud infrastructure and a recently closed $1 billion convertible notes offering. Community members are weighing the potential impact of this transition and the large capital infusion on IREN's growth prospects, while others debate whether the stock is overvalued. Bullish sentiment remains, with many anticipating significant gains and increased institutional interest.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing increased volatility as traders weigh geopolitical concerns, banking sector jitters, and potential impacts from upcoming economic reports. Community members are actively discussing potential downside risks and hedging strategies, while also debating whether the current market dip presents a buying opportunity or signals a larger correction.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels ($UUUU) is trending amidst discussions about its positioning in the rare earth element (REE) sector and potential government interest. Community members are weighing perspectives on the stock's valuation, recent price action, and the potential impact of U.S.-China trade dynamics on the REE market. The company's uranium assets and production capabilities are also being considered as factors influencing its future performance.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as investors discuss gold's safe-haven appeal amid dollar concerns and potential bond market issues. The community is debating whether the rally is sustainable, with some predicting further gains while others foresee a significant correction. Broader economic factors, including U.S.-China trade dynamics and potential Federal Reserve actions, are also fueling the conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders PR...

Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Akero Therapeutics, Inc. (NasdaqGS: AKRO) to...

CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza

Cidara Therapeutics wins FDA Breakthrough Therapy tag for CD388 for the prevention of seasonal influenza. Stock rises.

OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data

Ovid Therapeutics jumps 39% in a month after phase I epilepsy study data show superior efficacy of its lead candidate, OV329, hinting at best-in-class potential.

Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance?

NVO's $4.7B acquisition of Akero Therapeutics adds a late-stage MASH therapy to its obesity-linked pipeline, advancing its expansion goal beyond semaglutide.

U.S. equities declined in Thursday afternoon trade as Wall Street took a breather following a record-setting rally. The S&amp;P 500 and the Nasdaq Composite indexes both climbed to record highs on Thursday, before paring the gains and declining to trade in the red at the time of writing.Meanwhile, silver prices&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/silver-spot-price-50-first-time-4-decades/ch67qedR3K8">continued to climb</a> on Thursday. Spot silver prices climbed to a new high of $51.38 per troy ounce, rising more than 5% before paring most of the gains.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was down 0.41% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, fell 0.45%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, declined 0.52%.Here are the top stocks making the biggest moves in Thursday’s afternoon trade:<a href="https://stocktwits.com/symbol/DAL">Delta Air Lines Inc. (DAL)</a>Delta shares soared over 5% in Thursday’s afternoon trade after the airline’s third-quarter (Q3) results beat Wall Street expectations. Delta reported earnings per share (EPS) of $1.71 on revenue of $16.67 billion, beating analyst estimates of an EPS of $1.53 on revenue of $15.08 billion, according to Stocktwits data.<a href="https://stocktwits.com/symbol/DAL">DAL stock</a> is down 1% year-to-date.<a href="https://stocktwits.com/symbol/TLRY">Tilray Brands Inc. (TLRY)</a>Tilray Brands shares were up more than 23% in Thursday’s afternoon session after the company’s first-quarter (Q1)&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tilray-brands-stock-skyrockets-on-swing-to-profit-significant-debt-reduction/ch67ouWR3Kj">results</a> came in better than expectations. Tilray reported nil earnings per share (EPS) on revenue of $209.5 million, beating analyst estimates of a loss of $0.03 per share on revenue of $204.55 million, according to Stocktwits data.<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> is up 59% year-to-date.<a href="https://stocktwits.com/symbol/PATH">UiPath Inc. (PATH)</a>UiPath shares climbed 15% in Thursday’s afternoon trade, building on the gains over the past few trading sessions following the announcement of collaboration with OpenAI on enterprise agentic automation. The stock surged over 5% on Wednesday and hit new 2025&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ui-path-rises-extended-hours-after-hitting-new-2025-highs/ch67O1jR30f">highs</a> on AI momentum.<a href="https://stocktwits.com/symbol/PATH">PATH stock</a> is up 41% year-to-date.<a href="https://stocktwits.com/symbol/AKRO">Akero Therapeutics Inc. (AKRO)</a>Akero Therapeutics shares were up more than 16% on Thursday after the company announced that it had&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/akero-shares-rally-pre-market-after-announcing-acquisition-by-novo-nordisk/ch67VXUR3K7">entered</a> into a definitive agreement to be acquired by Novo Nordisk AS (NVO) for up to $5.2 billion in cash.<a href="https://stocktwits.com/symbol/AKRO">AKRO stock</a> is up 95% year-to-date.<a href="https://stocktwits.com/symbol/APGE">Apogee Therapeutics Inc. (APGE)</a>Apogee Therapeutics shares continued to gain on Thursday, rising more than 7% after surging 19% on Wednesday. The clinical-stage biotechnology company announced the pricing of a $300 million public offering at $41 per share.<a href="https://stocktwits.com/symbol/APGE">APGE stock</a> is up 12% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/silver-spot-price-50-first-time-4-decades/ch67qedR3K8">Silver Prices Hit $50 For First Time In Over 4 Decades</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today

Delta shares soared over 5% in Thursday’s afternoon trade after the airline’s third-quarter results beat Wall Street expectations.

Equity

Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Akero...

AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akero Therapeutics, Inc. (NASDAQ: AKRO) to Novo Nordisk A/S is fair to Akero shareholders. Under the terms of the...

U.S. stocks appear set for a cautious opening on Thursday as investors await a series of speeches from Federal Reserve officials, including Chair Jerome Powell, Vice Chair for Supervision Michelle Bowman, and a discussion between Fed Governor Michael Barr and Minneapolis Fed President Neel Kashkari.On Wednesday, the minutes of the Federal Open Market Committee’s (FOMC) September meeting were released,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-minutes-half-officials-expect-two-more-rate-cuts-by-end-of-2025/ch6EAFlR30c">highlighting concerns</a> among Fed officials about labor market weakness and the need for further rate cuts.While Dow Jones futures edged up by 0.01% at the time of writing, the S&amp;P 500 futures were down by 0.02%, while the tech-heavy Nasdaq 100’s futures fell 0.05%. Futures of the Russell 2000 index were down by 0.2%.Meanwhile, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) was down 0.04% at the time of writing. Invesco QQQ Trust (QQQ) fell 0.08% on Thursday morning, and the SPDR<a href="https://stocktwits.com/symbol/DIA"> Dow Jones Industrial Average ETF Trust</a> (DIA) gained 0.03%. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bearish’ territory.Asian markets ended Thursday’s trading session on a largely positive note, with the Nikkei 225 leading with gains of 1.6%, followed by the Shanghai Composite at 1.3%, and the TWSE Capitalization Weighted Stock index at 0.87%.The Hang Seng index declined 0.35%, while the KOSPI was closed for trading on account of Chuseok Festivity.Stocks To Watch<ul><li>Tesla Inc. (TSLA): The National Highway Traffic Safety Administration (NHTSA) opened a probe into nearly 2.9 million Tesla vehicles equipped with the company’s Full Self-Driving (FSD) system over more than 50 traffic safety violations and a few crashes. Tesla shares were down nearly 1% pre-market.</li><li>Novo Nordisk AS (NVO): Novo Nordisk has entered into a definitive agreement with Akero Therapeutics Inc. (AKRO) to acquire the latter in a $5.2 billion deal. Novo shares were down nearly 2% in Thursday’s pre-market session.</li><li>Delta Air Lines Inc. (DAL): Delta shares soared over 5% in Thursday’s pre-market trade after the airline’s third-quarter (Q3) results beat Wall Street expectations. Delta reported earnings per share (EPS) of $1.71 on revenue of $16.67 billion, beating analyst estimates of an EPS of $1.53 on revenue of $15.08 billion, according to Stocktwits data.</li><li>PepsiCo Inc. (PEP): PepsiCo shares gained nearly 2% pre-market after the company’s Q3 results beat Wall Street expectations. PepsiCo reported EPS of $2.29 on revenue of $23.94 billion, beating analyst estimates of an EPS of $2.26 on revenue of $23.84 billion, according to Stocktwits data.</li></ul>&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-minutes-half-officials-expect-two-more-rate-cuts-by-end-of-2025/ch6EAFlR30c">Fed Minutes Show Officials Agree Rate Cuts Needed, But Inflation Concerns Persist</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

People walk by the New York Stock Exchange

Dow Futures Inch Up As Wall Street Awaits Jerome Powell’s Speech: TSLA, NVO, DAL, PEP Among Stocks To Watch

While Dow Jones futures edged up by 0.01% at the time of writing, the S&P 500 futures were down by 0.02%.

Akero Therapeutics, Inc. (AKRO) announced on Thursday that it has entered into a definitive agreement to be acquired by Danish drugmaker Novo Nordisk (NVO) for up to $5.2 billion in cash.Akero shareholders will <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/09/3163964/0/en/Akero-Therapeutics-to-be-Acquired-by-Novo-Nordisk-for-up-to-5-2-Billion.html">receive</a> $54 per share in cash at closing in addition to a contingent value right that entitles holders to a cash payment of $6/ share upon full U.S. regulatory approval of Efruxifermin (EFX) for treatment of compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) by June 30, 2031.&nbsp;The upfront cash payment represents a premium of over 16% from the stock’s last closing price on Wednesday. <a href="https://stocktwits.com/symbol/AKRO">Shares of AKRO</a> soared 19% in Thursday’s pre-market session.On Stocktwits, retail sentiment around AKRO stock rose from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.Novo said that MASH is closely linked with its expertise in diabetes and obesity, with over 40% MASH patients also having type 2 diabetes, and over 80% of MASH patients being overweight or living with obesity.“If approved, we believe it (Efruxifermin) could become a cornerstone therapy, alone or together with Wegovy (semaglutide), to tackle one of the fastest-growing metabolic diseases of our time,” said Novo Nordisk CEO Mike Doustdar.The transaction is expected to close around year-end, the company said, subject to approval by Akero shareholders. It will also be debt-financed, it added.Novo <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916433">said</a> that the transaction is not expected to impact its previously communicated operating profit outlook for 2025. However, the free cash flow outlook for 2025 is expected to be negatively impacted by about $4 billion, it noted.In 2026, Novo expects the acquisition to increase research and development costs and negatively impact full-year operating profit growth by around three percentage points.AKRO shares rose 67% this year and by 63% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/delta-ceo-ed-bastian-says-airline-operations-unaffected-by-federal-government-shutdown-report/ch67Fg9R3Kf">Delta CEO Ed Bastian Says Airline Operations Unaffected By Federal Government Shutdown: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Akero Therapeutics is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

What’s Driving The Super Rally In Akero Shares On Thursday Morning?

Novo Nordisk is set to acquire the firm, and Akero’s shareholders will receive $54 per share in cash at closing in addition to a contingent value right. 

Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company was founded by Jonathan Young and Timothy Rolph in January 2017 and is headquartered in South San Francisco, CA.

Akero Therapeutics Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$53.66
Prev Close	$53.60
Open	$53.74
Dividend Yield	0.00%
50-Day Moving Average	$47.47
Beta	0.93
Avg. Volume	1.27M
PE Ratio	-14.10

52-Week High	$58.40
52-Week Low	$21.34
Market Capitalization	$4.3B
EPS (Annual)	-$3.75
Price to Book	4.18
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

AKRO
Akero Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AKRO News

AKROAkero Therapeutics Inc